Suppr超能文献

来自一名脊髓性肌萎缩症患者的诱导多能干细胞。

Induced pluripotent stem cells from a spinal muscular atrophy patient.

作者信息

Ebert Allison D, Yu Junying, Rose Ferrill F, Mattis Virginia B, Lorson Christian L, Thomson James A, Svendsen Clive N

机构信息

The Waisman Center, The Stem Cell and Regenerative Medicine Center, University of Wisconsin-Madison, 1500 Highland Avenue, Madison, Wisconsin 53705, USA.

出版信息

Nature. 2009 Jan 15;457(7227):277-80. doi: 10.1038/nature07677. Epub 2008 Dec 21.

Abstract

Spinal muscular atrophy is one of the most common inherited forms of neurological disease leading to infant mortality. Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death. Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiology which may underlie their vulnerability to the disease process. Here we report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy. These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother. This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathology seen in a genetically inherited disease. As such, it represents a promising resource to study disease mechanisms, screen new drug compounds and develop new therapies.

摘要

脊髓性肌萎缩症是导致婴儿死亡的最常见遗传性神经疾病之一。患者的下运动神经元选择性丧失,导致肌肉无力、瘫痪,常常死亡。尽管患者的成纤维细胞已被广泛用于研究脊髓性肌萎缩症,但运动神经元具有独特的解剖结构和生理特性,这可能是它们易受疾病进程影响的原因。在此,我们报告了从一名患有脊髓性肌萎缩症的儿童的皮肤成纤维细胞样本中诱导多能干细胞的生成。这些细胞在培养中强劲扩增,维持疾病基因型,并生成了与来自该儿童未受影响母亲的运动神经元相比表现出选择性缺陷的运动神经元。这是第一项表明人类诱导多能干细胞可用于模拟遗传性疾病中所见特定病理情况的研究。因此,它是研究疾病机制、筛选新药物化合物和开发新疗法的有前景的资源。

相似文献

1
Induced pluripotent stem cells from a spinal muscular atrophy patient.
Nature. 2009 Jan 15;457(7227):277-80. doi: 10.1038/nature07677. Epub 2008 Dec 21.
2
Stem cells: Tailor-made diseased neurons.
Nature. 2009 Jan 15;457(7227):269-70. doi: 10.1038/457269a.
6
Proteomic assessment of a cell model of spinal muscular atrophy.
BMC Neurosci. 2011 Mar 8;12:25. doi: 10.1186/1471-2202-12-25.
7
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy.
Sci Transl Med. 2012 Dec 19;4(165):165ra162. doi: 10.1126/scitranslmed.3004108.
8
Cell cycle inhibitors protect motor neurons in an organoid model of Spinal Muscular Atrophy.
Cell Death Dis. 2018 Oct 27;9(11):1100. doi: 10.1038/s41419-018-1081-0.
9
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA).
J Cell Mol Med. 2014 Feb;18(2):187-96. doi: 10.1111/jcmm.12224. Epub 2014 Jan 8.

引用本文的文献

2
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery.
Pharmacol Rev. 2025 Jun 26;77(5):100077. doi: 10.1016/j.pharmr.2025.100077.
3
Pluripotency genes of mammals: a network at work.
Front Bioeng Biotechnol. 2025 Jun 12;13:1578499. doi: 10.3389/fbioe.2025.1578499. eCollection 2025.
4
An organ-chip model of sporadic ALS using iPSC-derived spinal cord motor neurons and an integrated blood-brain-like barrier.
Cell Stem Cell. 2025 Jul 3;32(7):1139-1153.e7. doi: 10.1016/j.stem.2025.05.015. Epub 2025 Jun 24.
6
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases.
Int J Mol Sci. 2025 Apr 16;26(8):3774. doi: 10.3390/ijms26083774.
7
Cell reprogramming: methods, mechanisms and applications.
Cell Regen. 2025 Mar 27;14(1):12. doi: 10.1186/s13619-025-00229-x.
8
Patient-specific responses to splice-modifying treatments in spinal muscular atrophy fibroblasts.
Mol Ther Methods Clin Dev. 2024 Nov 13;32(4):101379. doi: 10.1016/j.omtm.2024.101379. eCollection 2024 Dec 12.
9
Proteomic and functional comparison between human induced and embryonic stem cells.
Elife. 2024 Nov 14;13:RP92025. doi: 10.7554/eLife.92025.
10
A longevity-specific bank of induced pluripotent stem cells from centenarians and their offspring.
Aging Cell. 2025 Jan;24(1):e14351. doi: 10.1111/acel.14351. Epub 2024 Sep 25.

本文引用的文献

1
Disease-specific induced pluripotent stem cells.
Cell. 2008 Sep 5;134(5):877-86. doi: 10.1016/j.cell.2008.07.041. Epub 2008 Aug 7.
2
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.
Science. 2008 Aug 29;321(5893):1218-21. doi: 10.1126/science.1158799. Epub 2008 Jul 31.
3
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.
Cell. 2008 Feb 22;132(4):567-82. doi: 10.1016/j.cell.2008.01.015.
4
Generation of human induced pluripotent stem cells from dermal fibroblasts.
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8. doi: 10.1073/pnas.0711983105. Epub 2008 Feb 15.
5
Reprogramming of human somatic cells to pluripotency with defined factors.
Nature. 2008 Jan 10;451(7175):141-6. doi: 10.1038/nature06534. Epub 2007 Dec 23.
6
Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation.
Stem Cells. 2008 Mar;26(3):715-23. doi: 10.1634/stemcells.2007-0368. Epub 2007 Nov 29.
7
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell. 2007 Nov 30;131(5):861-72. doi: 10.1016/j.cell.2007.11.019.
8
Induced pluripotent stem cell lines derived from human somatic cells.
Science. 2007 Dec 21;318(5858):1917-20. doi: 10.1126/science.1151526. Epub 2007 Nov 20.
9
Animal models of spinal muscular atrophy.
J Child Neurol. 2007 Aug;22(8):1004-12. doi: 10.1177/0883073807305667.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验